Intermediate-term outcome of 500 consecutive rapid-deployment surgical aortic valve procedures†.
Aortic valve replacement
Minimally invasive surgery
Rapid-deployment
Transvalvular gradient
Journal
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
ISSN: 1873-734X
Titre abrégé: Eur J Cardiothorac Surg
Pays: Germany
ID NLM: 8804069
Informations de publication
Date de publication:
01 Mar 2019
01 Mar 2019
Historique:
received:
16
04
2018
revised:
27
06
2018
accepted:
08
07
2018
pubmed:
24
8
2018
medline:
2
10
2020
entrez:
24
8
2018
Statut:
ppublish
Résumé
The Edwards INTUITY Valve System is a balloon-expandable bioprosthesis, inspired from the Edwards Magna valve and transcatheter technology, with a subvalvular stent frame to enable rapid deployment. We report a single-centre experience of aortic valve replacement with this novel bioprosthesis. Five hundred consecutive patients, of whom 45.6% were female with a mean age of 73.5 [standard deviation (SD) 7.9 years], with severe aortic stenosis who received a rapid deployment aortic valve between May 2010 and July 2017 were included in a prospective and ongoing database. The median follow-up time was 12 months, and the total accumulated follow-up time was 818 patient years. Preoperative characteristics, operative parameters, survival, valve-related adverse events and valve haemodynamics were assessed. Thirty-day mortality was 0.8% (4/500), and overall survival at 1, 3 and 5 years was 94%, 89% and 81%, respectively. A minimally invasive surgical approach was chosen in 236 patients (47%), of which 122 (24%) were operated on through an anterior right thoracotomy. Cross-clamp and cardiopulmonary bypass times for isolated aortic valve replacement were 53 (SD 17) and 89 (SD 29) min for full sternotomy as well as 75 (SD 23) and 110 (SD 31) min for minimally invasive surgery approaches (P < 0.001). Mean gradients at discharge, 1, 3 and 5 years were 13 (SD 5), 11 (SD 4), 12 (SD 5) and 11 (SD 3) mmHg, respectively. New pacemaker implantation was necessary in 8.6% of patients. A single case (0.2%) of structural degeneration was registered after 6 years. Valve explantation for non-structural dysfunction or endocarditis occurred in 9 patients (1.8%). This rapid deployment aortic valve has shown excellent results concerning haemodynamic performance, durability and safety. Implantation requires specific training, and the rate of pacemaker implantation remains a matter of concern. This novel valve also facilitates minimally invasive approaches and may be beneficial in complex combined procedures.
Identifiants
pubmed: 30137264
pii: 5076726
doi: 10.1093/ejcts/ezy273
pmc: PMC6381385
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
527-533Informations de copyright
© The Author(s) 2018. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery.
Références
Ann Thorac Surg. 2016 Feb;101(2):789-800
pubmed: 27175453
Eur J Cardiothorac Surg. 2017 Aug 1;52(2):281-287
pubmed: 28453629
JACC Cardiovasc Interv. 2017 Feb 13;10(3):268-275
pubmed: 28183466
J Thorac Cardiovasc Surg. 2017 Jul;154(1):32-43.e1
pubmed: 28433356
Ann Thorac Surg. 2017 Oct;104(4):1259-1264
pubmed: 28433222
J Am Heart Assoc. 2018 Feb 16;7(4):
pubmed: 29453309
Ann Thorac Surg. 2014 Oct;98(4):1294-300
pubmed: 25106682
Eur J Cardiothorac Surg. 2018 Oct 1;54(4):768-773
pubmed: 29617925
N Engl J Med. 2017 Apr 6;376(14):1321-1331
pubmed: 28304219
J Thorac Cardiovasc Surg. 2014 Dec;148(6):2854-60
pubmed: 25218544
N Engl J Med. 2016 Apr 28;374(17):1609-20
pubmed: 27040324
Lancet. 2016 May 28;387(10034):2218-25
pubmed: 27053442
J Thorac Cardiovasc Surg. 2013 Jan;145(1):110-5; discussion 115-6
pubmed: 23058665
EuroIntervention. 2018 Mar 20;13(16):1902-1903
pubmed: 29175769
Eur J Cardiothorac Surg. 2015 Oct;48(4):557-61
pubmed: 25527170
Interact Cardiovasc Thorac Surg. 2016 Jun;22(6):799-805
pubmed: 26976130
Lancet. 2015 Jun 20;385(9986):2477-84
pubmed: 25788234
JAMA Cardiol. 2016 Nov 1;1(8):945-949
pubmed: 27541162
Innovations (Phila). 2018 May/Jun;13(3):177-183
pubmed: 29912142
Eur J Cardiothorac Surg. 2008 Apr;33(4):523-8
pubmed: 18313319
Ann Thorac Surg. 1996 Aug;62(2):596-7
pubmed: 8694642
Ann Thorac Surg. 2015 Jan;99(1):17-25
pubmed: 25441065
Ann Thorac Surg. 2018 Jul;106(1):14-22
pubmed: 29630873
J Thorac Cardiovasc Surg. 2009 Mar;137(3):670-679.e5
pubmed: 19258087
J Am Soc Echocardiogr. 2009 Sep;22(9):975-1014; quiz 1082-4
pubmed: 19733789
Cardiovasc Eng Technol. 2017 Mar;8(1):17-29
pubmed: 27873180